<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Monkeypox</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Monkeypox.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/monkeypox.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Emerging infectious diseases (Mpox, Nipah, and Andes): A narrative review of transmission, environmental survival, and disinfection.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ajic-2026-06-003-a7a46760/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ajic-2026-06-003-a7a46760/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The review highlights that rapid identification of suspected cases and adherence to infection prevention recommendations are needed to prevent healthcare-associated transmission of these emerging viruses.</description>
    <category>Monkeypox</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Molecular cloning of a monkeypox virus clade IIb genome and construction of an attenuated mutant for basic and translational research.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2717859-54a0a08e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2717859-54a0a08e/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames the platform as a potential way to facilitate MPXV basic and applied research by enabling work with an attenuated virus. Its relevance is research infrastructure for antibody and antiviral testing, rather than evidence of population-level disease effects.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article frames precision vaccinology as relevant to mpox preparedness and development of vaccines intended to provide durable, clade-specific protection. The supplied abstract does not provide clinical effectiveness estimates or outcome data supporting a specific public health intervention.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>High mpox mortality in people living with HIV and immune suppression: Lessons from Sierra Leone for integrated outbreak preparedness and response</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The piece argues for integrated HIV/STI and mpox prevention and care, pre-exposure vaccination of at-risk people, continued investment in surveillance and data systems, and pre-approved emergency research protocols as part of outbreak preparedness, with a long-term aim beyond acute response.</description>
    <category>Monkeypox</category>
    <category>HIV infection</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>MPOX: ASPECTOS GERAIS E O USO DA ABORDAGEM &lt;i&gt;ONE HEALTH&lt;/i&gt; NO CONTEXTO DESSA ZOONOSE VIRAL</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-47820-recima21-v7i8-8836-59975ed1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-47820-recima21-v7i8-8836-59975ed1/</guid>
    <pubDate>Sat, 22 Aug 2026 00:00:00 GMT</pubDate>
    <description>The One Health approach, integrating actions across human, animal, and environmental health sectors, is relevant for addressing this zoonosis. Effective control requires prevention measures, effective public policies, interdisciplinary cooperation, and strengthened epidemiological surveillance.</description>
    <category>Monkeypox</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Dynamics of global mpox epidemics, 1970–2025: a systematic review and meta-analysis of evolving transmissibility and intervention effects</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022252-a4e4e58e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022252-a4e4e58e/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>Monitoring progressive changes in viral spread capabilities underscores the importance of timely, balanced resource distribution paired with localized educational initiatives to mitigate future transmission waves.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Monkeypox virus clade IIb isolate exhibits reduced virulence relative to clade IIa isolates in multiple murine models</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00247-26-5f2069b3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00247-26-5f2069b3/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Validating these murine platforms facilitates ongoing research into viral mechanisms and supports the evaluation of potential therapeutic strategies against divergent orthopoxvirus lineages.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Prevalence of mpox infection among men who have sex with men: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01493-y-6b24b880/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01493-y-6b24b880/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The pronounced regional disparities suggest that targeted geographic strategies and uniform monitoring protocols would enhance future outbreak management and funding distribution.</description>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Using protection motivation theory to predict monkeypox vaccination intention among adults in Chongqing, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1871884-92184832/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1871884-92184832/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that if monkeypox vaccines are included in future routine recommendations in China, public health interventions should emphasize disease severity, reduce perceived barriers to vaccination, and build confidence to increase uptake among populations with relatively low baseline willingness.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Dynamic modeling and optimal control of Mpox among MSM in a central Chinese city</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12889-026-28925-6-0a0b55e9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12889-026-28925-6-0a0b55e9/</guid>
    <pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings offer a quantitative basis for prioritizing resource distribution during localized mpox surges. They illustrate how adaptive management of prevention, screening, clinical access, and immunization can improve outbreak containment outcomes.</description>
    <category>Monkeypox</category>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>APOBEC3-driven attenuation of the 2022 global outbreak monkeypox virus relative to its clade IIb ancestor</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76580-7-00f2b79e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76580-7-00f2b79e/</guid>
    <pubDate>Tue, 11 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article is relevant to monkeypox outbreak investigation and transmission dynamics because it addresses phenotypic differences in a virus lineage associated with the 2022 global epidemic. Its focus on zoonotic MPXV and orthopoxvirus transmission gives it One Health relevance.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Operationalizing One Digital Health and FAIR Data Principles for Disease Surveillance in a Low-Medium Income Country in Africa: Qualitative Study in the Democratic Republic of the Congo.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</guid>
    <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
    <description>The analysis supplies practical guidance for resource-constrained regions aiming to replace disconnected digital projects with coordinated, compatible networks that support comprehensive pathogen tracking.</description>
    <category>COVID-19</category>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cross-reactive immunity against orthopoxviruses after monkeypox virus infection or smallpox vaccination</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109047-cef9afc2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109047-cef9afc2/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Monkeypox infection and smallpox vaccination may provide cross-protection against orthopoxviruses. Early IgA detection could support mpox diagnosis in asymptomatic high-risk individuals, and complement-dependent neutralization assays may improve cross-immunity assessment.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seminal fluid enhances monkeypox virus infection via amyloidogenic fibrils</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2703396-1f1820df/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2703396-1f1820df/</guid>
    <pubDate>Fri, 24 Jul 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that seminal amyloids act as host factors amplifying MPXV infectivity and broadening cell tropism, with potential implications for understanding sexual transmission of mpox.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessing human judgment forecasts in the rapid spread of the mpox outbreak: insights and challenges for pandemic preparedness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13621-y-c0f394fb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13621-y-c0f394fb/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings provide evidence about the potential use and limits of aggregated human judgment for outbreak forecasting and preparedness. The abstract suggests that forecasting platforms may need to address scale presentation, support the cues used by forecasters, and permit zero-probability assignments, but it does not establish effects on health outcomes or operational decisions.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>MVA-BN monkeypox vaccine safety in a clinical trial in the Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01490-0-faf40751/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01490-0-faf40751/</guid>
    <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
    <description>The findings provide additional evidence from an endemic setting that the MVA-BN vaccine, widely deployed for monkeypox prevention, is generally safe and well-tolerated with predominantly mild injection site reactions.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004893-4fe5ef5f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004893-4fe5ef5f/</guid>
    <pubDate>Tue, 03 Feb 2026 00:00:00 GMT</pubDate>
    <description>The article highlights a continuing disproportionate burden in Africa and persistent global risk, with relevance to maintaining a sustained response to mpox transmission.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</guid>
    <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
    <description>The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparedness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2025-08-019-736f724d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2025-08-019-736f724d/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The analysis highlights structural deficiencies in current observational research infrastructure that could delay coordinated responses during emerging infectious disease events. Standardizing data collection and maintaining continuous monitoring networks are presented as essential steps for timely public health interventions.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Unnoticed Entry, Noticed Transmission: Epidemiological Insights into China&apos;s First Clade Ib Monkeypox Virus Cluster.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-infdis-jiag143-2be936cc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-infdis-jiag143-2be936cc/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames the cluster as relevant to mpox surveillance and prevention because transmission was detected after negative entry screening in a returning traveler. It points to risk-based surveillance, diagnostic testing, and targeted prevention as response considerations.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessment of Epidemic Preparedness for Ebola Virus Disease and Hantavirus in the Kokolo Military Health Zone, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The report underscores the necessity for sustained resource allocation, supply chain optimization, and interagency cooperation to preserve outbreak resilience within defense healthcare networks confronting recurring and novel viral hazards.</description>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/</guid>
    <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
    <description>The article provides Germany-specific observational evidence on MVA-BN safety and estimated effectiveness in the population studied during the 2022-2023 mpox period. Its findings may inform editorial context about vaccination evidence, including the reported difference in estimated effectiveness by HIV status, but they do not establish causality or confirm a current surveillance pattern.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7422a3-e39ea2c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7422a3-e39ea2c9/</guid>
    <pubDate>Thu, 19 Jun 2025 00:00:00 GMT</pubDate>
    <description>The recommendations provide outbreak-specific vaccination guidance amid ongoing mpox transmission and substantial morbidity and mortality. Future need for the outbreak recommendation will be reassessed as the outbreak evolves.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mpox in Africa: What we know and what is still lacking</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013148-060ab7b4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013148-060ab7b4/</guid>
    <pubDate>Thu, 12 Jun 2025 00:00:00 GMT</pubDate>
    <description>The authors argue Mpox has the potential to disrupt health systems and undermine progress toward the 2030 sustainable development goals, calling for financial and human resource support from countries both within and outside Africa.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Transmission dynamics of the 2022 mpox epidemic in New York City</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03526-9-4f851f4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03526-9-4f851f4f/</guid>
    <pubDate>Tue, 25 Mar 2025 00:00:00 GMT</pubDate>
    <description>The findings indicate that mpox transmission in NYC followed general principles of sexually transmitted pathogen spread within highly connected sexual networks, which may inform expectations about outbreak trajectories in similar populations.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Viral genetics and transmission dynamics in the second wave of mpox outbreak in Portugal and forecasting public health scenarios</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2024-2412635-5235f344/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2024-2412635-5235f344/</guid>
    <pubDate>Fri, 11 Oct 2024 00:00:00 GMT</pubDate>
    <description>Scenario analysis projects that small increases in the high sexual activity MSM population can trigger new waves. Findings support continued vaccination, targeted awareness in risk groups, and routine genomic surveillance to anticipate novel threats including global dissemination of clade I viruses.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Assessing vaccine strategies for mpox outbreak in New York City using an age-structure model</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09551-2-a3a237a7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09551-2-a3a237a7/</guid>
    <pubDate>Mon, 30 Sep 2024 00:00:00 GMT</pubDate>
    <description>The paper argues that current vaccine coverage is sufficient to prevent large-scale mpox resurgence in New York City even with a similar gathering event, and that limited vaccine doses in other settings should prioritize high-risk individuals aged 34–45 years.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-38-2400575-f7a0beb2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-38-2400575-f7a0beb2/</guid>
    <pubDate>Thu, 19 Sep 2024 00:00:00 GMT</pubDate>
    <description>The findings indicate that antibody responses to MVA-BN vaccination may not persist beyond one year, highlighting the need for ongoing surveillance to assess the public health implications of declining antibody levels for mpox outbreak preparedness.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2024-107132-f6683eae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2024-107132-f6683eae/</guid>
    <pubDate>Sun, 01 Sep 2024 00:00:00 GMT</pubDate>
    <description>Understanding which factors contributed to the waning of the 2022 mpox epidemic can inform outbreak response strategies and help anticipate future transmission dynamics in similar settings.</description>
    <category>Monkeypox</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Clinical features and viral load variations of Mpox: a retrospective study in Chongqing, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09537-0-7b95053e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09537-0-7b95053e/</guid>
    <pubDate>Wed, 26 Jun 2024 00:00:00 GMT</pubDate>
    <description>The authors position the work as relevant to targeted prevention, control, and treatment planning for mpox in MSM and people living with HIV. The abstract also frames the sampling results as supporting attention to direct physical contact, especially at genital and anal sites, in the study context.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00451-6-f4ce6dd3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00451-6-f4ce6dd3/</guid>
    <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
    <description>The findings suggest that reductions in sexual partner rates among some GBMSM drove the outbreak reversal, and that timely vaccination helped limit future resurgences, informing control strategies for future mpox outbreaks.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Mpox in people with past infection or a complete vaccination course: a global case series</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00492-9-83571f46/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00492-9-83571f46/</guid>
    <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
    <description>Cataloging symptom profiles in previously immune populations aids researchers in understanding how prior exposure modifies disease presentation within affected networks.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Phylogeny and molecular evolution of the first local monkeypox virus cluster in Guangdong Province, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-023-44092-3-bd1cafab/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-023-44092-3-bd1cafab/</guid>
    <pubDate>Tue, 12 Dec 2023 00:00:00 GMT</pubDate>
    <description>The findings are positioned by the authors as contributing to understanding of the ongoing mpox outbreak in China and to informing joint prevention and control strategies.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Stability of Monkeypox Virus in Body Fluids and Wastewater</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2910-230824-dc98821b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2910-230824-dc98821b/</guid>
    <pubDate>Sun, 01 Oct 2023 00:00:00 GMT</pubDate>
    <description>Findings indicate that sufficient environmental MPXV stability could support transmission in healthcare settings, where exposure and dose-response are likely limiting factors.</description>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-023-02542-x-78e2381a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-023-02542-x-78e2381a/</guid>
    <pubDate>Mon, 11 Sep 2023 00:00:00 GMT</pubDate>
    <description>The abstract presents genomic epidemiology as a potential tool for monitoring and controlling mpox outbreaks in real time. It also states that the findings may inform future vaccine policy for a population described as highly susceptible; this is an article-level implication rather than clinical or policy advice.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Health policy</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</guid>
    <pubDate>Thu, 29 Jun 2023 00:00:00 GMT</pubDate>
    <description>The findings support the usefulness of JYNNEOS vaccination against mpox disease and suggest greater protection with completion of the two-dose series, relevant to U.S. outbreak control among at-risk adults.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2023-28-12-2200772-971f344b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2023-28-12-2200772-971f344b/</guid>
    <pubDate>Thu, 23 Mar 2023 00:00:00 GMT</pubDate>
    <description>The findings characterize a high-incidence mpox outbreak in a specific population and provide quantitative estimates of vaccine protection, contributing evidence relevant to vaccination strategy and risk communication for at-risk communities.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Monkeypox outbreak in the Tel Aviv District, Israel, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2022-12-023-5071231c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2022-12-023-5071231c/</guid>
    <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
    <description>The report underscores the operational value of targeted immunization strategies for vulnerable demographics and emphasizes continuous monitoring to mitigate future regional spread.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Air and surface sampling for monkeypox virus in a UK hospital: an observational study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-22-00257-9-c7980a75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-22-00257-9-c7980a75/</guid>
    <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
    <description>The findings demonstrate environmental contamination in isolation facilities and potential for airborne suspension of monkeypox virus during specific activities such as bedding changes. Contamination of healthcare worker PPE and doffing areas underscores the importance of infection control protocols, proper PPE use, and doffing procedures in preventing nosocomial transmission.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-022-02090-w-3f5be3bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-022-02090-w-3f5be3bf/</guid>
    <pubDate>Tue, 18 Oct 2022 00:00:00 GMT</pubDate>
    <description>These observations address knowledge gaps surrounding authorized MVA-BN deployment during a recently declared international health emergency by quantifying early immune responses.</description>
    <category>Influenza</category>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2810-221047-17f0876f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2810-221047-17f0876f/</guid>
    <pubDate>Sat, 01 Oct 2022 00:00:00 GMT</pubDate>
    <description>The findings document environmental surface contamination and recovery of viable virus in a household setting; the abstract states that most positive cultures had low titers, indicating limited potential for indirect transmission.</description>
    <category>Monkeypox</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-022-01907-y-f9db9841/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-022-01907-y-f9db9841/</guid>
    <pubDate>Fri, 24 Jun 2022 00:00:00 GMT</pubDate>
    <description>The findings indicate that genomic sequencing may provide information for investigating the spread and transmission of monkeypox virus during an outbreak. The supplied evidence does not establish clinical effects, intervention effectiveness, or a current public health risk level.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>The changing epidemiology of human monkeypox—A potential threat? A systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010141-156f368b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010141-156f368b/</guid>
    <pubDate>Fri, 11 Feb 2022 00:00:00 GMT</pubDate>
    <description>The review highlights the global relevance of monkeypox given its spread beyond endemic African settings and suggests that enhanced surveillance is needed to monitor its evolving epidemiology.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Travel medicine</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>One Health</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Isolation and Characterization of Monkeypox Virus from the First Case of Monkeypox — Chongqing Municipality, China, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-46234-ccdcw2022-206-aa7b378f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-46234-ccdcw2022-206-aa7b378f/</guid>
    <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
    <description>The abstract states that the isolated strain and the reported infectious-titration and neutralization methods provide resources and technical platforms for further research, including antiviral and vaccine development.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2002-130118-e5d287f8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2002-130118-e5d287f8/</guid>
    <pubDate>Sat, 01 Feb 2014 00:00:00 GMT</pubDate>
    <description>The authors call for improved surveillance to monitor potential adaptation of monkeypox virus to humans.</description>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
